Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation
Li-Yu Chen,Chen-Yu Wang,Chi-Ying Lin,Ming-Jui Tsai,Wei-Hsun Shen,Pei-Jhih Li,Lin-Chu Liao,Chih-Fen Huang,Chien-Chih Wu
DOI: https://doi.org/10.2147/idr.s477414
2024-09-27
Infection and Drug Resistance
Abstract:Li-Yu Chen, 1 Chen-Yu Wang, 1, 2 Chi-Ying Lin, 3 Ming-Jui Tsai, 3 Wei-Hsun Shen, 1 Pei-Jhih Li, 1 Lin-Chu Liao, 1 Chih-Fen Huang, 4, 5 Chien-Chih Wu 4 1 Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 2 National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan; 3 Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4 Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; 5 School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan Correspondence: Chien-Chih Wu, Department of Pharmacy, National Taiwan University Hospital, 7 Chung Shan S. Road, Taipei, Taiwan, Email ; Background: In the field of postoperative care, infections caused by Gram-positive bacteria pose a major clinical challenge. Vancomycin is a key therapeutic agent whose efficacy is greatly influenced by renal function, particularly by augmented renal clearance (ARC). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) is an easy and commonly used method to predict ARC; however, it is not well studied to determine vancomycin dose. In this study, we examined the effectiveness of the CKD-EPI equation in determining ARC and optimizing the dose of vancomycin for surgical ward patients. Methodology: A retrospective observational study was conducted to examine 158 surgical ward patients receiving vancomycin. Data on demographics, medical history, and vancomycin dosing were collected. Renal function was evaluated using the CKD-EPI equation, with ARC defined as eGFR ≥ 96.5 mL/min/1.73 m 2 . Vancomycin pharmacokinetics were calculated using the ClinCalc tool. Results: ARC was in 54% of the patients. Compared with patients without ARC, those with ARC were younger and had lower serum creatinine levels. They also required higher vancomycin doses but had lower trough concentrations and 24-hour area-under-the-curve values. A significant correlation was observed between eGFR and vancomycin clearance, with eGFR > 96.5 mL/min/1.73 m 2 necessitating higher vancomycin doses (> 45 mg/kg/day) to achieve the desired area under the curve to minimum inhibitory concentration ratio. Conclusion: For surgical ward patients with CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m 2 , a vancomycin dosage of > 45 mg/kg/day may be recommended to reach effective therapeutic levels. Overall, this study emphasizes the importance of tailoring vancomycin therapy depending on renal function to ensure efficacy and mitigate the risk of antimicrobial resistance in surgical ward patients. Keywords: augmented renal clearance, vancomycin, surgery Postoperative infection is a common complication of surgery, which may prolong hospitalization and affect prognosis. 1 Gram-positive bacteria are often involved in postoperative infections. 2 With the emergence of drug-resistant strains, vancomycin plays a key role in combating infections caused by Gram-positive bacteria, particularly by Staphylococcus aureus . 3–5 The pharmacokinetic/pharmacodynamic (PK/PD) target of vancomycin is defined as the ratio between the area under the curve (AUC) and the minimum inhibitory concentration (MIC), with an optimal target range of 400 to 600 to ensure efficacy and reduce nephrotoxicity. 4 Optimizing the PK/PD target of antibiotics can improve clinical outcomes. 6 AUC/MIC monitoring is primarily recommended for serious methicillin-resistant Staphylococcus aureus (MRSA) infections, such as bacteremia, infective endocarditis, and pneumonia, due to its stronger correlation with clinical outcomes. 4 It is also preferred for patients at high risk of nephrotoxicity, including critically ill patients, patients with unstable renal function, and those on prolonged vancomycin therapy. 4 Trough-only monitoring is no longer recommended due to the higher likelihood of achieving an AUC/MIC >400 with trough concentrations between 10 and 15 mg/L, and the increased risk of nephrotoxicity when trough concentrations exceed 15 mg/L. 7,8 Moreover, numerous studies have demonstrated that AUC-guided monitoring reduces the risk of nephrotoxicity compared to trough-only monitoring. 9 Currently, only for patients undergoing hemodialysis, pre-dialysis concentrations with a target range of 15–20 mg/L are used instead of targeting AUC/MIC. 10 Therefore, identifying the factors affecting the PK/PD target and promptly adjusti -Abstract Truncated-
pharmacology & pharmacy,infectious diseases